← Leaderboards
Suresh Kumar
National Institute On Aging
$0
Attributed
$0
Total exposure
0
Grants
0
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding mix
By agency
—
By mechanism
—
Top collaborators
No co-investigators on record.
Most similar at National Institute On Aging
Same institution · by research overlap
Others in their field
Top investigators on “Cancer Care”
- Larry Arthur$259,898,406
- David Heimbrook · Leidos Biomedical Research, Inc.$247,870,139
- Peter C Adamson · National Childhood Cancer Foundation$237,824,162
- Ethan Dmitrovsky · Leidos Biomedical Research, Inc.$227,757,130
- Gregory H Reaman · National Childhood Cancer Foundation$185,461,069
- Philip J Disaia · University Of California Irvine$144,322,261
Research focus
Cancer CareMalignant NeoplasmsQuality Of LifeStrategic PlanningMutationMutantProteinsOncogenicAge RelatedAffectCancer SurvivorCancer PatientGeneticBiology Of AgingBiologyAmino AcidsBiochemicalCcne1 GeneBinding ProteinsCdkn2a GeneCarcinogenesisCancer TherapyBindingAtp-Binding Cassette Transporters
Grant awards (6)
Oncogenic Function of FBXW7 R465 mutation reveals a new opportunity for cancer therapy$15,316
ZIA · FY2020 · AG · contact PI
RAC1 Signaling Studies and Resistance to Pharmacological Inhibition of MAPK in Cancer Harboring RAC1 29S Hotspot Mutation$10,211
ZIA · FY2020 · AG · contact PI
Oncogenic Function of FBXW7 R465 mutation reveals a new opportunity for cancer therapy$395,245
ZIA · FY2019 · AG · contact PI
RAC1 Signaling Studies and Resistance to Pharmacological Inhibition of MAPK in Cancer Harboring RAC1 29S Hotspot Mutation$343,019
ZIA · FY2019 · AG · contact PI
RAC1 Signaling Studies and Resistance to Pharmacological Inhibition of MAPK in Cancer Harboring RAC1 29S Hotspot Mutation$754,487
ZIA · FY2018 · AG · contact PI
Oncogenic Function of FBXW7 R465 mutation reveals a new opportunity for cancer therapy$754,487
ZIA · FY2018 · AG · contact PI